AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33012083 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine plus Methotrexate (CsA/Mtx)
Number of subjects: 141
Study 36401662 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (70 mL, 6.4 mmol NO3−)
Number of subjects: 11
Study 36401662 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70 mL, 0.04 mmol NO3−)
Number of subjects: 11
Study 35397572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus clausii (oral suspension of 2 billion spores per 5 mL bottle) plus oral rehydration therapy (ORT) and zinc
Number of subjects: 454
Study 35397572 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus oral rehydration therapy (ORT) and zinc
Number of subjects: 454
Study 35397572 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus clausii
Number of subjects: 454
Study 35397572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 454
Study 35594726 — intervention group
Group type: EXPERIMENTAL
Intervention: Body positive social media content
Number of subjects: 261
Study 35594726 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-and-toned ideal social media content
Number of subjects: 261
Study 35594726 — intervention group
Group type: COMPARATOR
Intervention: Neutral travel condition
Number of subjects: 261
Study 32156239 — intervention group
Group type: COMPARATOR
Intervention: Thiopental (4 mg/kg)
Number of subjects: 100
Study 32156239 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (4 mg/kg) + Ketamine (0.5 mg/kg)
Number of subjects: 100
Study 32171439 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training 3 times/week for 6 months
Number of subjects: 30
Study 32171439 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care and counseling)
Number of subjects: 30
Study 36219460 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel enriched with sodium alginate and vitamins A and E
Number of subjects: 26
Study 36219460 — intervention group
Group type: COMPARATOR
Intervention: Control group (cleaning and a simple dressing)
Number of subjects: 26
Study 36219460 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel treatment
Number of subjects: 26
Study 33492010 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage contact lens (BCL) exchange on the first postoperative day
Number of subjects: 56
Study 33492010 — intervention group
Group type: COMPARATOR
Intervention: Control group (BCL not exchanged)
Number of subjects: 56
Study 33492010 — intervention group
Group type: EXPERIMENTAL
Intervention: A-PRK
Number of subjects: 56
Study 33492010 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-PRK
Number of subjects: 56
Study 34898074 — intervention group
Group type: EXPERIMENTAL
Intervention: Luobufukebiri Pills (LP), 10 pills bid for 12 weeks
Number of subjects: 206
Study 34898074 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E soft capsules, 100 mg bid for 12 weeks
Number of subjects: 206
Study 34898074 — intervention group
Group type: EXPERIMENTAL
Intervention: Luobufukebiri Pills (LP) vs Vitamin E soft capsules
Number of subjects: 206
Study 36344978 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intensive treatment
Number of subjects: 317
Study 36344978 — intervention group
Group type: COMPARATOR
Intervention: High-risk group (4 risk factors)
Number of subjects: 317
Study 36344978 — intervention group
Group type: COMPARATOR
Intervention: Intermediate risk group (2-3 risk factors)
Number of subjects: 317
Study 36344978 — intervention group
Group type: COMPARATOR
Intervention: Absent/low risk group (0-1 risk factor)
Number of subjects: 317
Study 35717146 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (90-minute weekly sessions for 6 weeks plus two booster sessions)
Number of subjects: 800
Study 35717146 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 800
Study 32200410 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert surgeon (group 1)
Number of subjects: 60
Study 32200410 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert E-BLUS tutor (group 2)
Number of subjects: 60
Study 32200410 — intervention group
Group type: EXPERIMENTAL
Intervention: E-BLUS guide alone (group 3)
Number of subjects: 60
Study 32200410 — intervention group
Group type: COMPARATOR
Intervention: No tutor (group 4)
Number of subjects: 60
Study 2005275508 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 30
Study 2005275508 — intervention group
Group type: COMPARATOR
Intervention: Proprioceptive Neuromuscular Facilitation (PNF)
Number of subjects: 30
Study 33567460 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment with Bryonia alba (33.3%), Arsenicum album (18.1%), Pulsatilla nigricans (13.8%), Nux vomica (8%), Rhus toxicodendron (7.2%), Gelsemium sempervirens (5.8%) in 30C potency
Number of subjects: 196
Study 33567460 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (details not specified)
Number of subjects: 196
Study 33175003 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental trauma (specifically avulsion)
Number of subjects: 571
Study 33175003 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries experience
Number of subjects: 571
Study 33175003 — intervention group
Group type: EXPERIMENTAL
Intervention: Income
Number of subjects: 571
Study 35342994 — intervention group
Group type: COMPARATOR
Intervention: CoQ10 phytosome acute supplementation
Number of subjects: 20
Study 35342994 — intervention group
Group type: COMPARATOR
Intervention: CoQ10 phytosome middle-term supplementation
Number of subjects: 20
Study 33658007 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed hemodynamic management (maintaining stroke volume variation < 6%, cardiac index 3.0-4.0 L/min/m2, mean arterial pressure > 95 mmHg with crystalloid fluids and infusion of dobutamine and/or norepinephrine)
Number of subjects: 144
Study 33658007 — intervention group
Group type: COMPARATOR
Intervention: Routine hemodynamic management (control group)
Number of subjects: 144
Study 33658007 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed hemodynamic management
Number of subjects: 144
Study 33658007 — intervention group
Group type: COMPARATOR
Intervention: Routine hemodynamic management
Number of subjects: 144
Study 32028833 — intervention group
Group type: EXPERIMENTAL
Intervention: I3C/PROVE IT!
Number of subjects: 237
Study 32028833 — intervention group
Group type: COMPARATOR
Intervention: business-as-usual
Number of subjects: 237
Study 36055329 — intervention group
Group type: EXPERIMENTAL
Intervention: Short treatment with a carbapenem
Number of subjects: 0
Study 36055329 — intervention group
Group type: COMPARATOR
Intervention: Extended treatment with a carbapenem
Number of subjects: 0
Study 33575989 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Methylprednisolone (IVMP) 30 mg/kg/d for 3 days followed by oral prednisolone taper
Number of subjects: 60
Study 33575989 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Methylprednisolone (IVMP)
Number of subjects: 60
Study 33575989 — intervention group
Group type: COMPARATOR
Intervention: Oral Prednisolone (OP) 4 mg/kg/d for two weeks followed by taper
Number of subjects: 60
Study 33575989 — intervention group
Group type: COMPARATOR
Intervention: Oral Prednisolone (OP)
Number of subjects: 60
Study 36017797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets (3.5 mg/kg, approved dose)
Number of subjects: 870
Study 36017797 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dummy pill)
Number of subjects: 870
Study 36029412 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 3 mg/kg (ipi3)
Number of subjects: 549
Study 36029412 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 10 mg/kg (ipi10)
Number of subjects: 549
Study 36029412 — intervention group
Group type: COMPARATOR
Intervention: high-dose interferon (HDI)
Number of subjects: 549
Study 33616033 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach group (n = 32)
Number of subjects: 71
Study 33616033 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group (n = 39)
Number of subjects: 71
Study 32324651 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (ADL) treatment
Number of subjects: 66
Study 34407734 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemna protein concentrate (LPC)
Number of subjects: 12
Study 34407734 — intervention group
Group type: COMPARATOR
Intervention: Whey protein concentrate (WPC)
Number of subjects: 12
Study 33512814 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block with 20 mL 0.5% bupivacaine
Number of subjects: 60
Study 33512814 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia using Ranawat cocktail (60 mL applied to subacromial space and glenohumeral joint)
Number of subjects: 60
Study 32387225 — intervention group
Group type: EXPERIMENTAL
Intervention: His Bundle Pacing (HBP)
Number of subjects: 137
Study 32387225 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Pacing (LBBP)
Number of subjects: 137
Study 32387225 — intervention group
Group type: COMPARATOR
Intervention: Biventricular Pacing (BVP)
Number of subjects: 137
Study 36037698 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga practice
Number of subjects: 0
Study 36037698 — intervention group
Group type: COMPARATOR
Intervention: Control (no yoga practice)
Number of subjects: 0
Study 34636255 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1 + tucatinib
Number of subjects: 0
Study 34636255 — intervention group
Group type: COMPARATOR
Intervention: T-DM1 + placebo
Number of subjects: 0
Study 33909203 — intervention group
Group type: EXPERIMENTAL
Intervention: Neratinib + capecitabine (N + C)
Number of subjects: 621
Study 33909203 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib + capecitabine (L + C)
Number of subjects: 621
Study 34973707 — intervention group
Group type: EXPERIMENTAL
Intervention: RF toothbrush (ToothWave, Home Skinovations)
Number of subjects: 86
Study 34973707 — intervention group
Group type: COMPARATOR
Intervention: Sonic vibrating toothbrush (SmileSonic powered toothbrush, Ranir)
Number of subjects: 86
Study 34103270 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Midwifery Program (CMP)
Number of subjects: 221
Study 34103270 — intervention group
Group type: COMPARATOR
Intervention: Midwifery Antenatal Care (MAC)
Number of subjects: 221
Study 34103270 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 221
Study 32523546 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) use
Number of subjects: 53
Study 32523546 — intervention group
Group type: COMPARATOR
Intervention: Naturally hormonally cycling (AthletesNC)
Number of subjects: 53
Study 33539256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine in-situ gel
Number of subjects: 216
Study 33041263 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNAP exercise group (SG, n=15)
Number of subjects: 24
Study 33041263 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n=9)
Number of subjects: 24
Study 36128174 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS) in the experimental group (neoadjuvant chemotherapy + surgery)
Number of subjects: 0
Study 36128174 — intervention group
Group type: EXPERIMENTAL
Intervention: CT examination in the experimental group (neoadjuvant chemotherapy + surgery)
Number of subjects: 0
Study 36128174 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ultrasonography (EUS) in the control group (conventional surgery)
Number of subjects: 0
Study 36128174 — intervention group
Group type: COMPARATOR
Intervention: CT examination in the control group (conventional surgery)
Number of subjects: 0
Study 33051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest postoperative haemoglobin concentration <110 g L−1
Number of subjects: 7227
Study 33051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative haemoglobin concentrations <88 g L−1
Number of subjects: 7227
Study 33051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative haemoglobin concentrations >113 g L−1
Number of subjects: 7227
Study 33051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient population
Number of subjects: 7227
Study 33051083 — intervention group
Group type: COMPARATOR
Intervention: Patients with lowest postoperative haemoglobin concentration >110 g L−1
Number of subjects: 7227
Study 34597534 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for up to 96 weeks
Number of subjects: 2282
Study 34597534 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for up to 148 weeks (subgroup analysis)
Number of subjects: 2282
Study 32516486 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR-T intervention
Number of subjects: 295
Study 32516486 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 295
Study 37561251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% FML eye drops once every half hour (Group C)
Number of subjects: 180
Study 37561251 — intervention group
Group type: COMPARATOR
Intervention: 0.1% FML eye drops once every hour (Group B)
Number of subjects: 180
Study 37561251 — intervention group
Group type: COMPARATOR
Intervention: No FML (Group A)
Number of subjects: 180
Study 34368943 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual (SL) 50 mg ketamine lozenge
Number of subjects: 23
Study 34368943 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral (PO) 50 mg ketamine lozenge
Number of subjects: 23
Study 34368943 — intervention group
Group type: COMPARATOR
Intervention: SL placebo lozenge
Number of subjects: 23
Study 34368943 — intervention group
Group type: COMPARATOR
Intervention: PO placebo lozenge
Number of subjects: 23
Study 32540886 — intervention group
Group type: EXPERIMENTAL
Intervention: Two approaches to improving Lynch syndrome detection
Number of subjects: 0
Study 32540886 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation Leads and Lynch syndrome stakeholders
Number of subjects: 0
Study 32540886 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team meetings
Number of subjects: 0
Study 32540886 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidelity checklists and project log analysis
Number of subjects: 0
Study 33884453 — intervention group
Group type: EXPERIMENTAL
Intervention: Double coraco‐clavicular tunnel technique in an anatomical configuration (DCTa)
Number of subjects: 13
Study 33884453 — intervention group
Group type: COMPARATOR
Intervention: Double coraco‐clavicular tunnel technique in an inverse configuration of the anatomical position (DCTb)
Number of subjects: 13
Study 33031349 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula
Number of subjects: 759
Study 33031349 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive positive pressure ventilation
Number of subjects: 759
Study 32692244 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at 2.310 mg/kg (EC50) in group B
Number of subjects: 40
Study 32692244 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at 3.567 mg/kg (EC50) in group M
Number of subjects: 40
Study 34895775 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-concordant health coaching intervention
Number of subjects: 64
Study 34895775 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 36171989 — intervention group
Group type: EXPERIMENTAL
Intervention: 1MSTSIND (individually adapted seat height to 90° knee flexion)
Number of subjects: 49
Study 36171989 — intervention group
Group type: COMPARATOR
Intervention: 1MSTSSTD (standard chair seat height of 46 cm)
Number of subjects: 49
Study 33297967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia care toolbox (including patient brochures, information cards, and posters) mailed to GP practices.
Number of subjects: 50
Study 36346279 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation for 6 months
Number of subjects: 0
Study 36346279 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study 34819447 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 72
Study 34819447 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs + Diacerein
Number of subjects: 72
Study 32142514 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention for smoking cessation over 12 weeks
Number of subjects: 535
Study 32142514 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 535
Study 33930277 — intervention group
Group type: EXPERIMENTAL
Intervention: High pressure (100% resting limb occlusion pressure, 20% one-repetition maximum)
Number of subjects: 20
Study 33930277 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate pressure (50% resting limb occlusion pressure, 20% one-repetition maximum)
Number of subjects: 20
Study 33930277 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (TRT; 70% one-repetition maximum)
Number of subjects: 20
Study 33332416 — intervention group
Group type: EXPERIMENTAL
Intervention: Food frequency questionnaire (FFQ) for marine n-3FA consumption
Number of subjects: 132
Study 33332416 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma phospholipid (PL) marine n-3FA levels
Number of subjects: 132
Study 33332416 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between FFQ estimates and plasma PL marine n-3FA levels
Number of subjects: 132
Study 32202181 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training plus supervised spinal mobility exercises, 3 days a week for 12 weeks
Number of subjects: 31
Study 32202181 — intervention group
Group type: COMPARATOR
Intervention: Supervised spinal mobility exercises only, 3 times a week for 12 weeks
Number of subjects: 31
Study 35466101 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 148
Study 35466101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 35466101 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (NAC and nutraceuticals)
Number of subjects: 148
Study 33470329 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAPT) - aspirin, ticagrelor, and tirofiban
Number of subjects: 162
Study 33470329 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAPT) - aspirin and ticagrelor
Number of subjects: 162
Study 34897103 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS‐VR group
Number of subjects: 40
Study 34897103 — intervention group
Group type: COMPARATOR
Intervention: rTMS group
Number of subjects: 40
Study 32340846 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dimensional printing templates for cervical lateral mass screw insertion (Group A)
Number of subjects: 6
Study 32340846 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique for cervical lateral mass screw insertion (Group B)
Number of subjects: 6
Study 35149905 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated root dentin with conventional resin cement (RelyX ARC, 3 M ESPE)
Number of subjects: 40
Study 35149905 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated root dentin with self-adhesive resin cement (RelyX U200, 3 M ESPE)
Number of subjects: 40
Study 35149905 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated root dentin with conventional resin cement (RelyX ARC, 3 M ESPE)
Number of subjects: 40
Study 35149905 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated root dentin with self-adhesive resin cement (RelyX U200, 3 M ESPE)
Number of subjects: 40
Study 35149905 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated root dentin
Number of subjects: 40
Study 35470190 — intervention group
Group type: EXPERIMENTAL
Intervention: SPACE FOR COPD programme (home-based manual and 4, 2-hour group sessions over 12 months)
Number of subjects: 116
Study 35470190 — intervention group
Group type: EXPERIMENTAL
Intervention: SPACE FOR COPD programme
Number of subjects: 116
Study 35470190 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 116
Study 34693756 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-min bouts of light-intensity walking every 30 min of sitting (BR)
Number of subjects: 15
Study 34693756 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min bout of moderate-to-vigorous exercise followed by prolonged sitting (EX)
Number of subjects: 15
Study 34693756 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting (SIT)
Number of subjects: 15
Study 35427205 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib 10 mg
Number of subjects: 100
Study 35427205 — intervention group
Group type: COMPARATOR
Intervention: Lenvima® 10 mg
Number of subjects: 100
Study 34129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving ≥7 critical care endpoints
Number of subjects: 6052
Study 34129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor blood pH
Number of subjects: 6052
Study 34129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of dopamine during donor management
Number of subjects: 6052
Study 34129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volumes ≤8 ml/kg predicted body weight
Number of subjects: 6052
Study 34129720 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher positive end-expiratory pressures
Number of subjects: 6052
Study 32544575 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (HFRT) - 40 Gy/15 fractions, 45 Gy/15 fractions, 45 Gy/20 fractions
Number of subjects: 117
Study 32544575 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated radiation therapy (CFRT) - 60 Gy/30 fractions or 66 Gy/33 fractions
Number of subjects: 117
Study 32544575 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (HFRT)
Number of subjects: 117
Study 32544575 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated radiation therapy (CFRT)
Number of subjects: 117
Study 36259089 — intervention group
Group type: COMPARATOR
Intervention: 3 + Q12W (fixed dosing regimen with injections every 12 weeks)
Number of subjects: 249
Study 33058884 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard myotomy
Number of subjects: 100
Study 33058884 — intervention group
Group type: EXPERIMENTAL
Intervention: Short myotomy
Number of subjects: 100
Study 32113878 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone 3 mg vaginally
Number of subjects: 130
Study 32113878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130